Germany · Delayed Price · Currency is EUR Almirall Company Description
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations.
It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology.
The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009.
Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
| Country | Spain |
| Founded | 1943 |
| Industry | Pharmaceutical Preparations |
| Employees | 2,026 |
| CEO | Carlos Gallardo Piqué |
Contact Details
Address: Ronda General Mitre, 151 Barcelona, 08022 Spain | |
| Phone | 34 93 291 30 00 |
| Website | almirall.com |
Stock Details
| Ticker Symbol | E2Z |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Carlos Gallardo Piqué | Chief Executive Officer |
| Michael McClellan | Chief Financial Officer |
| Pablo del Fraile | Head of Investor Relations |